Skip to main content
OpenTrials

Clinical trial condition

MCL

Explore clinical trials studying MCL. Study availability and eligibility vary by location and protocol.

10 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

MCL trial results

Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

NCT06697184

Conditions
CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +22 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

NCT03625037

Conditions
Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Chronic Disease, DLBCL, +26 more
Locations
  • Arizona Mayo Clinic Phoenix, Arizona, United States
  • University of California at San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 85 locations
View Trial Details
Active, Not Recruiting

A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma

NCT06192888

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Dana Farber Cancer Institute (Data Collection and Specimen Analysis) Boston, Massachusetts, United States
  • Mayo Clinic (Data Collection Only) Rochester, Minnesota, United States
  • Washington University (Data Collection Only) St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
View Trial Details
Active, Not Recruiting

Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma

NCT05214183

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Department of Hematology X, Odense University Hospital Odense, Denmark
  • Department of Hematology, Zeeland University Hospital Roskilde Roskilde, Denmark
  • Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center Helsinki, Finland
  • Oulu University Hospital Oulu, Finland
View all 20 locations
View Trial Details

Related conditions